In people with mild cognitive impairment, up to one drink of alcohol a day may slow their progression to dementia, according to a study published in the May 22, 2007, issue of Neurology?, the scientific journal of the American Academy of Neurology.
Mayo Clinic researchers and a group of international collaborators have discovered a correlation between an extreme form of sleep disorder and eventual onset of parkinsonism or dementia. The findings appear in the current issue of the journal Brain.
Dementia may be avoidable and doctors should take a more optimistic approach to the condition, according to research involving two UNSW academics.
Researchers from four organizations have identified more than 200 new proteins that bind to normal and mutant forms of the protein that causes Huntington’s disease (HD).
Scientists from the Center for Applied Medical Research (CIMA) from the University of Navarra investigate whether cardiotrophin 1, a molecule that can be measured in blood, can be used as a diagnostic marker for hypertensive cardiopathy.
A Mayo Clinic research team led by neurologist David Knopman, M.D. will join a nationwide consortium of leading Alzheimer’s disease researchers in a large-scale clinical trial evaluating the effectiveness of omega-3 fatty acids in slowing the progression of Alzheimer’s disease.
Scientists from the Center for Applied Medical Research from the University of Navarra investigate whether cardiotrophin 1, a molecule that can be measured in blood, can be used as a diagnostic marker for hypertensive cardiopathy.
The funding will ensure the establishment of a world-class facility that will accommodate significantgrowth in the area of dementia research. With this financial support realised, and the initial projectdesign completed, work on this vital development can now move ahead immediately.
Scientists have developed a novel strategy for tackling neurodegenerative diseases such as Huntington’s disease: encouraging an individual’s own cells to “eat” the malformed proteins that lead to the disease.
Some high blood pressure medicines may help protect older adults from declines in memory and other cognitive function, according to new research from Wake Forest University School of Medicine, reported today at the annual meeting of the American Geriatrics Society in Seattle.